Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02990650
Other study ID # STU00001977
Secondary ID
Status Completed
Phase Phase 1
First received October 16, 2016
Last updated January 18, 2017
Start date October 2008

Study information

Verified date October 2016
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Using a randomized controlled research design, compare walking outcomes resulting from gait and balance training with standard physical therapist interaction versus training with the addition of a KineAssist® robotic system that provides for safety and freedom of movement.


Description:

Several studies have investigated the use of balance and gait training and have demonstrated significant improvements in walking speed with trained stroke survivors. The inherent risks associated with balance and gait training requires the therapist to be vigilant with providing safety and support during challenging tasks. As a result, consumers are not challenged to their furthest limits and therapists put an inordinate amount of physical effort into safety control. KineAssist® Design, LLC in collaboration with Rehabilitation Institute of Chicago, developed the KineAssist® Balance and Gait Training System (KineAssist®). The KineAssist® is a novel device that allows full freedom of motion for the trunk and pelvis during gait and balance tasks, with additional postural control to enhance balance stability. These functions are available while the device follows the individual overground with minimal interference. The availability of postural control during complex and omnidirectional movement tasks allows the clinician to guarantee consumer safety and body weight support while at the same time provide graded task challenges to the fullest limits of the consumers capabilities. This KineAssist® is revolutionary in that it is the first device that is fully interactive and responsive to the movements and intentions of both the consumer and the therapist during overground challenging balance and gait activities.

Accordingly, the long-term objective of this research is to test the efficacy of robotically enhanced, progressive gait and balance training for improving walking outcomes post-stroke. The following two aims are designed to test whether the KineAssist® provides a more challenging training environment than is typical with physical therapy, and then compares walking outcomes as a result of long-term (6 weeks) training.

Aim: Using a randomized controlled research design, compare walking outcomes resulting from gait and balance training with standard physical therapist interaction versus training with the addition of a KineAssist®t.

Overall, these studies are an important advance for the development of effective clinical interventions for individuals with impaired locomotor ability post-stroke. This study will provide critical information on physiological effects and clinical outcomes and provide important evidence for the use of this new class of robotic technology that accommodates both the clinician and the consumer in stroke rehabilitation.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

- > 6 months post-stroke

- post-stroke hemiparesis

- 1.0 m/sec or slower walking speed

Exclusion Criteria:

- musculoskeletal injury

- recent history of cardiac event

- other neurological disease or disorders

- inability to follow three-step commands

- uncontrolled diabetes and/or high blood pressure

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Balance Task Training with therapist guarding support
Nine balance tasks: long forward step forward reach push forward push backward step over hurdle step up on foam surface step up on solid surface sit-to-stand step onto slippery surface The therapist will provide guarding support
Balance task training with robotic guarding support
Nine balance tasks: long forward step forward reach push forward push backward step over hurdle step up on foam surface step up on solid surface sit-to-stand step onto slippery surface The guarding support will be provided by a robot
Challneged balance task training with robotic guarding support
Nine balance tasks where the subject is challenged to perform at a harder level of difficulty: long forward step forward reach push forward push backward step over hurdle step up on foam surface step up on solid surface sit-to-stand step onto slippery surface The guarding support will be provided by a robot

Locations

Country Name City State
United States Locomotor Control Lab Birmingham Alabama

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham Rehabilitation Institute of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean time of 10 meter walk test at baseline baseline
Primary Mean time of 10 meter walk test at 3 weeks post baseline 3 weeks post baseline
Primary Mean time of 10 meter walk test at 6 weeks at end of training 6 weeks post baseline
Primary Mean time of 10 meter walk test at 6 months post training 6 months post end of training
Primary Mean time of 6 minute walk test at baseline baseline
Primary Mean time of 6 minute walk test at 3 weeks post baseline 3 weeks post baseline
Primary Mean time of 6 minute walk test at 6 weeks post baseline (end of training) 6 weeks post baseline (end of training)
Primary Mean time of 6 minute walk test at 6 months post training 6 months post end of training (7.5 months post baseline)
Primary Mean Berg Balance Scale score at baseline The Berg Balance Scale has a range of 56 (best) to 14 (worst). There are 14 different balance tasks each with a an assigned rank of 1 - 4 (1, 2, 3, 4). 1 is the worst performance and 4 is the best. baseline
Primary Mean Berg Balance Scale score at 3 weeks post baseline The Berg Balance Scale has a range of 56 (best) to 14 (worst). There are 14 different balance tasks each with a an assigned rank of 1 - 4 (1, 2, 3, 4). 1 is the worst performance and 4 is the best. 3 weeks post baseline
Primary Mean Berg Balance Scale score at 6 weeks post baseline (end of training) The Berg Balance Scale has a range of 56 (best) to 14 (worst). There are 14 different balance tasks each with a an assigned rank of 1 - 4 (1, 2, 3, 4). 1 is the worst performance and 4 is the best. 6 weeks post baseline
Primary Mean Berg Balance Scale score at 6 months post end of training The Berg Balance Scale has a range of 56 (best) to 14 (worst). There are 14 different balance tasks each with a an assigned rank of 1 - 4 (1, 2, 3, 4). 1 is the worst performance and 4 is the best. 6 months post end of training (7.5 months post baseline)
See also
  Status Clinical Trial Phase
Completed NCT05477238 - Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls N/A
Completed NCT00046293 - ReoPro and Retavase to Treat Acute Stroke Phase 2
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Completed NCT01116544 - Treatment of Chronic Stroke With AMES + EMG Biofeedback N/A
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Active, not recruiting NCT02563886 - Electrically Assisted Movement Therapy N/A
Recruiting NCT02446730 - Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Phase 4
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Recruiting NCT01769326 - Influence of Timing on Motor Learning N/A
Recruiting NCT02557737 - Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities Phase 3
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Completed NCT01423201 - Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT01656876 - The Effects of Mirror Therapy on Upper Extremity in Stroke Patients N/A
Completed NCT00542256 - tDCS and Physical Therapy in Stroke N/A
Withdrawn NCT00573092 - Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs N/A
Completed NCT00377689 - Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke Phase 2
Recruiting NCT00166751 - Sonographic Assessment of Laryngeal Elevation N/A
Completed NCT00125619 - Internally Versus Externally Guided Body Weight-Supported Treadmill Training (BWSTT) for Locomotor Recovery Post-stroke N/A